First Pacific Advisors, LP Medtronic PLC Transaction History

First Pacific Advisors, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$99.53 - $127.75 $288,637 - $370,475	-2,900 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$111.18 - $119.74 $57,702 - $62,145	-519 Reduced 15.18%	2,900 $343,000
Q4 2020 Feb 09, 2021	SELL	$100.57 - $117.14 $10,660 - $12,416	-106 Reduced 3.01%	3,419 $401,000
Q3 2020 Nov 13, 2020	SELL	$90.13 - $108.78 $137,448 - $165,889	-1,525 Reduced 30.2%	3,525 $366,000
Q2 2020 Aug 11, 2020	BUY	$84.11 - $103.33 $92,521 - $113,663	1,100 Added 27.85%	5,050 $463,000
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $21,037 - $24,845	250 Added 6.76%	3,950 $385,000
Q1 2019 May 14, 2019	SELL	$82.45 - $93.79 $8,245 - $9,379	-100 Reduced 2.63%	3,700 $337,000
Q4 2018 Feb 13, 2019	SELL	$85.8 - $99.49 $441,870 - $512,373	-5,150 Reduced 57.54%	3,800 $346,000
Q2 2018 Aug 13, 2018	SELL	$77.48 - $87.83 $577,226 - $654,333	-7,450 Reduced 45.43%	8,950 $766,000
Q1 2018 May 14, 2018	BUY	$76.55 - $87.26 $853,532 - $972,949	11,150 Added 212.38%	16,400 $1.32 Million
Q4 2017 Feb 12, 2018	BUY	$76.93 - $83.5 $403,882 - $438,375	5,250	5,250 $424,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $113B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of First Pacific Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on First Pacific Advisors, LP with notifications on news.